Oxford Nanopore Updates Share Capital After Option Exercises

An update from Oxford Nanopore Technologies PLC ( (GB:ONT) ) is now available.

Oxford Nanopore Technologies has issued 190,389 new ordinary shares following the exercise of options under its share option plans and the operation of certain remuneration schemes, with these shares admitted to the FCA’s Official List and trading on the London Stock Exchange under its existing block listing facility. Following this issuance, the company’s total issued share capital stands at 967,098,047 ordinary shares with no treasury shares, establishing the updated total voting rights figure that shareholders must use to assess and report any notifiable interests or changes in holdings under UK disclosure rules.

The block listing facility still allows Oxford Nanopore to admit a further 5,427,157 ordinary shares, indicating continued capacity to satisfy future option exercises or share-based remuneration without requiring a separate full listing process. The updated share and voting rights data provides clarity and compliance with the FCA’s transparency regime, ensuring investors and other stakeholders have an accurate denominator for calculating their ownership stakes and disclosure obligations.

The most recent analyst rating on (GB:ONT) stock is a Hold with a £159.00 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.

Spark’s Take on GB:ONT Stock

According to Spark, TipRanks’ AI Analyst, GB:ONT is a Neutral.

The score is driven primarily by moderate financial strength (revenue growth and strong equity base) offset by ongoing losses and negative cash flow. Technicals are supportive but look overextended, while valuation remains pressured by unprofitability. Earnings guidance is constructive, but sentiment includes meaningful operational challenges.

To see Spark’s full report on GB:ONT stock, click here.

More about Oxford Nanopore Technologies PLC

Oxford Nanopore Technologies plc is a UK-listed company operating in the life sciences and biotechnology sector, focused on developing and commercialising nanopore-based DNA and RNA sequencing technologies. Its shares are traded on the London Stock Exchange’s main market, and the company uses share option and remuneration schemes as part of its incentive and compensation structures.

Average Trading Volume: 1,598,541

Technical Sentiment Signal: Strong Sell

Current Market Cap: £1.29B

Learn more about ONT stock on TipRanks’ Stock Analysis page.